baber/WOPTO huggingface dataset:
Patent CA-2371567-A1 (CA)
Inventor: UPP DANIEL C
IPC: H04Q11/04
Filed: 2000-04-19
Abstract: An apparatus (100) having separate line side inlet queue (104, 106, 108, 110 , 112, 114, 116) for each GFR VC, a single network side outlet queue (132, 134 , 136, 138) for all GFR VCs, a single network side inlet queue (142, 144, 146,  148) for all GFR VCs, a single line outlet bulk processing queue with a post  queue packet processor (156) followed by separate line side outlet queues (160, 162, 164, 166) for each line, a network side outlet queue monitor (132 ), and a line side inlet queue controller (126). The network side outlet queue monitor is coupled to the line side inlet queue controller so that the netwo rk side outlet queue monitor can send messages to the line side inlet queue controller whereby the controller is directed to send data from the line sid e GFR queues based on the status network side outlet GFR queue.
Patent CA-2371667-A1 (CA)
Inventor: POPOVSKI GEORGE IVANOV
IPC: F16B7/04
Filed: 2002-02-14
Abstract: A connection device in which a hook member is carried in a casing member for both rotation about an axis of the hook member and movement longitudinally of the hook member inwardly and outwardly relative the casing.  An actuating member is provided to displace the hook member simultaneously for rotation and axial movement. The connection device is particularly adapted to be used as an element of a releasable joint for modular frame construction of frame members having T-shaped longitudinally extending slots. With the hook member in an unlocked position, the hook member extends from one frame member carrying the hook member and permits passage into a slot of another frame member with the hook member in the slot in the unlocked position, the hook member may be moved to a locked position by rotation and withdrawal of the hook member relative the frame member by which it is carried so as to catch the head of the hook member in the T-shaped slot and draw the two frame members together.
Patent CA-2372991-A1 (CA)
Inventor: CAHOON EDGAR BENJAMIN
IPC: A23K1/16
Filed: 2000-08-15
Abstract: The preparation and use of nucleic acid fragments encoding plant fatty acid modifying enzymes associated with modification of the delta-9 position of fatty acids, in particular, formation of conjugated double bonds are disclosed. Chimeric genes incorporating such nucleic acid fragments and suitable regulatory sequences can be used to create transgenic plants having  altered lipid profiles. The preparation and use of nucleic acid fragments encoding plant fatty acid modifying enzymes associated with formation of a trans delta-12 double bond also are disclosed. Chimeric genes incorporating such nucleic acid fragments and suitable regulatory sequences can be used to  create transgenic plants having altered lipid profiles.
Patent CA-2373715-A1 (CA)
Title: Method and system for fusing a spinal region
Inventor: HELM GREGORY A
IPC: A61F2/00
Filed: 2000-05-08
Abstract: A method and system for fusing a region in the spine involve the use of at least one guide tube (10a) to pass instruments and substances into the spina l region in a minimally invasive manner. In the preferred practice of the method, a guide tube is anchored to a vertebra and the guide tube is moved t o thereby position the vertebra. A steerable drilling tool (20a) is passed through the guide tube and steered into position to abrade at least a portio n of an intervertebral disc, thereby creating a cavity in the disc. A flowing substance is passed into the cavity and permitted to solidify to establish fusion in the cavity. Optionally, an uninflated balloon (40) is inserted int o the cavity and the balloon is filled with the flowing substance to contain t he flowing substance.
Patent CA-2377937-A1 (CA)
Title: Oligonucleotides de recepteur type 1 de glutamate metabotropique (mglur1)
Inventor: HENRY JAMES L
IPC: A61K38/00
Filed: 2000-07-17
Abstract: La présente invention concerne des oligonucléotides antisens de récepteur type 1 de glutamate métabotropique (mGluR¿1?). Cette invention a également trait à des oligonucléotides qui s'hybrident à un ARNm codant mGluR¿1? ou un variant d'épissure correspondant, à une méthode de traitement d'un patient souffrant d'un trouble lié à un taux de glutamate élevé, tel qu'une douleur chronique, ou d'amélioration d'un effet opioïde ou de diminution d'une dépendance et/ou tolérance opioïde consistant à administrer un tel oligonucléotide. On obtient ainsi un traitement spécifique de la douleur.
Patent CA-2379336-A1 (CA)
Title: Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease
Inventor: CHARLES MARIE-HELENE
IPC: A61P17/02
Filed: 2000-07-17
Abstract: Use of at least one polypeptide (A), containing at least fragment of a protein (B) selected from 28 sequences described in the specification, or having at least 70%, preferably 98% homology, to (B) or a fragment of one of the stated proteins, for detecting, preventing or treating a degenerative, neurological and/or auto-immune disease. The sequences belong to the perlecan, precursor of the retinol-binding plasma protein, precursor of the ganglioside GM2 activator, calgranulin B or saposin B protein families. Independent claims are also included for the following: (a) use of nucleic acids (C) that encode (A), or of the ligands (L) of (A) for detecting, preventing or treating a degenerative, neurological and/or autoimmune disease as for (A); (b) use of (A) for preparation of immunogenic peptides; (c) method for detecting (A), associated with a disease, by contacting (A) with (L) to form a complex of a complex or vice versa; (d) polypeptide (A1) with a 193 amino acid sequence described in the specification, or fragments of it, provided these include at least one mutation relative to another 193 amino acid sequence (8) described in the specification; (e) use of (A1) in the same ways as (A); (f) nucleic acid (C1) encoding (A1); (g) use of (C1) in the same ways as (C); (h) method for detecting (A) and (A1) by mass spectrometry; (i) diagnostic and prognostic method based on measuring at least one (A); (j) use of (A), (C) or recombinant proteins encoded by (C), for testing the efficacy of therapeutic agents or for producing a pharmaceutical composition; and (k) use of lycorin to produce a composition for preventing or treating a degenerative, neurological and/or autoimmune disease. ACTIVITY : Antineurodegeneration; Immunomodulatory. MECHANISM OF ACTION : Vaccine; Gene therapy.
Patent CA-2381717-A1 (CA)
Title: Determining properties of magnetic elements
Inventor: ENGLAND JAMES MARK CARSON
IPC: G06K19/06
Filed: 2000-08-11
Abstract: A method of determining differing characteristics of magnetic dipole element s such as orientation, coercivity, bias and response amplitude and a tag reade r for reading magnetic tags containing such elements. The elements are scanned  by a rotating magnetic field and two sets of transition data are determined.  The transition data sets are associated with respective elements and analyse d to determine mean field values resolved along the element vectors. These fie ld values are used to determine properties of the elements, such as coercivity.
Patent CA-2383050-A1 (CA)
Inventor: SHINDO JIRO
IPC: G06F21/10
Filed: 2000-08-28
Abstract: An image distributing system comprises clients (2) connectable through a network environment such as the Internet (1), an image file server (3) having an image file database (5) where image files are stored and a log file (6), a user database (7), and a security control server (4) having an image key database (8) and a log file (9). A client who has requested an image makes an access to the security control server by means of an IP address that the client obtains from the image file server is authenticated, obtains an image key, can open image data from the image file server, encodes the security data including the date and time of the delivery of the image data, the user ID, the serial number of the hard disk, and the IP address of the client, buries the security data as electronic watermark in the image data developed on the own memory, sends the data to the security control server, and allows the server to store it in the log file.
Patent CA-2385090-A1 (CA)
Inventor: SALTIEL ALAN ROBERT
IPC: C12N1/15
Filed: 2000-10-17
Abstract: The present invention relates to novel polynucleotides that contain peroxiso me proliferator response elements (PPREs). The invention also describes vectors  and host cells comprising the novel polynucleotides. The invention further describes methods for using the novel polynucleotides, gene therapy applications, diagnostics for syndromes involving insulin resistance, development of proprietary screening strategies for inhibitors of ligands or  proteins that bind to, associate with, or interact with the CAP promoter.</S DOAB>
Patent CA-2385663-A1 (CA)
Inventor: CARLSON CHRISTER
IPC: G01J3/52
Filed: 2000-09-20
Abstract: The invention concerns a reference card for the use as a reference object concerning light reflection and colour balance in photographing, which reference card has a neutral grey colour and reflects a predetermined amount of light. The back of the reference card provided with a releasable adhesive and that a number of reference cards are assembled in a pad (1), on a sheet (8) or attached to a strip (7) which is stored in a rolled-up position so that the reference cards are protected from light by each other. The invention also concerns a method of manufacturing said inventive reference card, whereby the colour in question of the card is applied by spraying or painting so that it opaquely cover the card.
Patent CA-2387098-A1 (CA)
Title: 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation
Inventor: EKWURIBE NNOCHIRI N
IPC: A61K31/167
Filed: 2000-10-27
Abstract: The present invention provides compositions useful for the treatment of inflammation in humans, and related methods of treatment for the same. In on e embodiment the composition is formula (A). In another embodiment, the composition is formula (B). In yet another embodiment, the composition is formula (C). Additional alternative embodiments are R or R" that are therapeutic moieties.
Patent CA-2389035-A1 (CA)
Inventor: TAYA NAOKI
IPC: B32B27/00
Filed: 2001-02-26
Abstract: A heat-shrinkable film which is based on a polyolefin and is suitable for use as a label to be attached to PET bottles, etc. Weight reduction, solvent sealability, and transparency are improved. The heat-shrinkable polyolefin film consists of a laminate comprising surface layers made of a resin material consisting mainly of a specific cycloolefin resin and an interlayer made of a resin material consisting mainly of a polyethylene resin.
Patent CA-2390029-A1 (CA)
Title: Suspension comprising oxcarbazepine
Inventor: BILLINGTON MICHAEL
IPC: A61K47/38
Filed: 2000-12-19
Abstract: This invention provides a pharmaceutical composition in the form of a suspension comprising oxcarbazepine
Patent CA-2392673-A1 (CA)
Title: Comparative genomic hybridization (cgh)
Inventor: WALDMAN FREDERIC
IPC: C12Q1/68
Filed: 1993-03-01
Abstract: Disclosed are new methods comprising the use of in situ hybridization to detect abnormal nucleic acid sequence copy numbers in one or more genomes wherein repetitive sequences that bind to multiple loci in a reference chromosome spread are either substantially removed and/or their hybridization signals suppressed. The invention termed Comparative Genomic Hybridization (CGH) provides for methods of determining the relative number of copies of nucleic acid sequences in one or more subject genomes or portions thereof (for example, a tumor cell) as a function of the location of those sequences in a reference genome (for example, a normal human genome). The intensity(ies) of the signals from each labeled subject nucleic acid and/or the differences in the ratios between different signals from the labeled subject nucleic acid sequences are compared to determine the relative copy numbers of the nucleic acid sequences in the one or more subject genomes as a function of position along the reference chromosome spread. Amplifications, duplications and/or deletions in the subject genome(s) can be detected. Also provided is a method of determining the absolute copy numbers of substantially all RNA or DNA sequences in subject cell(s) or cell population(s).
Patent CA-2393575-A1 (CA)
Inventor: WEEKS IAN
IPC: C12Q1/6818
Filed: 2000-12-11
Abstract: La présente invention concerne la surveillance des processus de construction des oligonucléotides au moyen d'un oligonucléotide sonde qui, pour l'une des réalisations, est marqué en l'une de ses extrémités d'un marqueur chimio-luminescent, et à l'autre extrémité d'une molécule atténuatrice. La conformation de l'oligonucléotide sonde se modifie dans la mesure où la sonde s'hybride avec une séquence d'acide nucléique sensiblement complémentaire. A l'état non hybridé, le marqueur chimio-luminescent est suffisamment proche de l'atténuateur pour que l'émission chimio-luminescente s'atténue nettement, alors qu'à l'état hybridé, la séparation est telle qu'il n'y a pratiquement pas, voire absolument pas d'atténuation. L'invention concerne également des sondes particulières ainsi que des paires émetteur - atténuateur.
Patent CA-2395926-A1 (CA)
Title: Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
Inventor: LEACH MARTIN
IPC: C12Q1/6883
Filed: 2000-12-28
Abstract: L'invention concerne des acides nucléiques contenant des polymorphismes mononucléotidiques identifiés pour des séquences humaines transcrites, ainsi qu'à des procédés d'utilisation de ces acides nucléiques.
Patent CA-2396402-A1 (CA)
Inventor: KLUG KARL H
IPC: C01B3/34
Filed: 2002-07-29
Abstract: The invention relates to a method and devices for the chemical reaction of liquid, vapor or gaseous hydrocarbons with either water or water vapor and either air or oxygen, to produce a hydrogen-rich synthesized gas for use in fuel cells. In the process, the chemical reaction of the reactants takes place on the catalytically coated surface of a material that is electrically conductive, and as a consequence of the feeding an electrical voltage, directly heatable and consequently temperature-controllable.
Patent CA-2396552-A1 (CA)
Title: Systems and methods for electronically managing digital subscriber line (dsl) telecommunications connections
Inventor: CAIN ROBERT M
IPC: H04M11/06
Filed: 2000-12-14
Abstract: Electronically establishing communication line cross-connections involves providing a controllable matrix of relays and a plurality of filters. A  composite signal comprising low and high frequency components is received at the relay matrix, which is controlled to direct the composite signal to a particular filter. A filtered low frequency component is provided at a particular filer output. The relay matrix is controlled to direct at least the high frequency component to a relay matrix output. The low frequency component of the composite signal may comprise a voice band signal and the high frequency component of the composite signal may comprise a data signal. The relay matrix may be controlled locally or remotely. The relay matrix may be controlled to significantly reduce the number of inactive connections established between digital access multiplexers and a main distribution frame or voice switch.
Patent CA-2397488-A1 (CA)
Title: Cream and sugar display stand and dispenser
Inventor: TREMBLAY CHRISTIAN
IPC: A47F5/04
Filed: 2002-08-12
Abstract: A holder for creamers having a tapered side wall, the holder comprising a housing having supporting members or feet extending downwardly therefrom, a plurality of openings in the housing, each being sized to retain a dairy creamer inserted therein, and a central opening located in a central portion of the housing such that a carrier may be used to transport a plurality of holders and the holder may be placed on a display stand at the table.
Patent CA-2398870-A1 (CA)
Title: Electron beam array for surface treatment
Inventor: WAKALOPULOS GEORGE
IPC: H01J31/00
Filed: 1994-05-23
Abstract: An array of electron beam tubes (152, 156. 158) is mounted on a conduc-tive place (91, 109, 123) for projecting stripe-like electron beam (163, 164, 165) through air onto a substrate (101) beneath the plate. The tubes each have a narrow beam window (51) formed by a very thin low-Z film layer (73), supported by silicon (71) and sealing the tube against ambi-ent pressure. Such windows produce low beam attenuation and allow low extrac-tion voltages to be used, thereby reducing beam energy which would otherwise be lost by penetration through a surface to be treated. The stripe-like output electron beam segments (113, 115) may be formed into a linear beam track so that the en-tire widthwise extent of a surface, such as a sheet or web (121), may be treated by electron beam irradiation or the beam segments may be formed into any desired composite beam pattern. In another em-bodiment the stripe-like output beam seg-ments may be arranged in an array to treat a circular circumferential surface, such as a cable.
Patent CA-2400175-A1 (CA)
Title: Method and apparatus for separating material
Inventor: JAMISON RUSSELL E
IPC: B02C15/04
Filed: 2001-02-22
Abstract: An apparatus for separating particles composed of a mixture of particles with differing physical and chemical characteristics comprising: a comminutor (201, 202) for reducing the size of the particles; a removal mechanism (7) for removing particles between the feed (3) and the comminutor; a removal mechanism (8) for removing particles from the comminutor to a size classification apparatus (2); a mechanism (16) for returning the oversized particles back to the comminutor or discharging them to a reject stream (17); and a magnetic and electric mechanism (figure 9) for separating the particles. A method for separating includes: reducing the size of the particles; removing the particles from comminution; providing particles to a separation mechanism; separating the particles based on size, density or electric and magnetic properties; and returning the appropriate particles to the comminutor.
Patent CA-2400541-A1 (CA)
Title: Positional control device for sectional doors
Inventor: ENGLISH WILLIAM
IPC: E05C17/00
Filed: 2002-08-30
Abstract: A positional control device is provided to prevent accidental drifting of an overhead sectional door upward or downward from a fully opened, partly opened or fully closed position. The device allows the door to be manually moved to a different elevation without requiring a separate operation to release the door from its original position. This is achieved by a mechanism which couples the upward and downward motion of the door to the rotation of a sprocket wheel engaged with a spring loaded ratchet arm with a bifurcated head specially shaped for ratcheting engagement with the teeth of the sprocket wheel. Suitable adjustment of the spring allows the ratchet mechanism to hold the door in its given position by exerting a force which can readily be overcome by manual raising or lowering the door to a different position.
Patent CA-2400970-A1 (CA)
Inventor: MOSBAUGH JAMES
IPC: A61L9/04
Filed: 2001-02-23
Abstract: L'invention concerne un procédé de moulage d'une agglomération de microsphères fusionnées pour créer un système de diffusion de parfum par l'utilisation de liants durcissant à température ambiante. L'agglomération prévitreuse moulée présente une durée de libération de parfum prolongée dépassant un an et demi, et elle utilise une action microcapillaire pour absorber rapidement des huiles et des alcools. L'agglomération prévitreuse moulée procure une libération lente de parfum sans qu'aucun liquide résiduel ne s'échappe. L'agglomération prévitreuse moulée peut être remplie, un nombre de fois illimité, d'huiles et d'alcools contenant des parfums une fois que l'odeur a cessé. Les agglomérations prévitreuses moulées peuvent aussi être colorées ou teintées.
Patent CA-2401219-A1 (CA)
Inventor: HANKELN THOMAS
IPC: C12N1/21
Filed: 2001-02-19
Abstract: Neuroglobine, acide nucléique codant pour une telle protéine et procédé de préparation de cette protéine. La présente invention concerne en outre des anticorps contre cette protéine ainsi que l'utilisation dudit ADN et de cette protéine pour le diagnostic et/ou la thérapie de maladies du système nerveux.
Patent CA-2401968-A1 (CA)
Title: Intermetallic compound superconductors and alloy superconductors, and methods of making them
Inventor: AKIMITSU JUN
IPC: H01L39/12
Filed: 2001-07-24
Abstract: There are provided an intermetallic compound superconductor that is high in superconducting transition temperature, and an alloy superconductor that is high in superconducting transition temperature and excels in malleability and ductility, as well as a method of making such a superconductor with good reproducibility and at a low cost of manufacture. This entirely new intermetallic compound superconductor is made of magnesium (Mg) and boron (B) and has a chemical composition expressed by formula: Mg1B2, has a hexagonal AlB2 type crystallographic structure and has a superconducting transition temperature (T c) of 39 K. An alloy containing this intermetallic compound excels in malleability and ductility and constitutes the alloy superconductor having a superconducting transition temperature (T c) of 39 K. In the method of manufacture, a Mg containing feedstock powder and a B containing feedstock powder are mixed together to form a mixture thereof which is, e.g., hot pressed to produce a semiconductor product.
Patent CA-2403459-A1 (CA)
Title: Ion conducting ceramic membrane and surface treatment
Inventor: MAZANEC TERRY JOSEPH
IPC: B01D69/00
Filed: 2001-03-15
Abstract: The present invention provides an ion conducting ceramic membrane selectively permeable to a gas, for instance oxygen and a method of treating such a membrane to improve permeation through the membrane. The membrane is formed by a mass of a substance through which ions of the gas migrate. The mass has two opposed surfaces where dissociation and ionization of the gas occurs and gas ions release electrons and recombine to form molecules of the gas, respectively. At least one of said two opposed surfaces is treated by a removal of surface material to produce surface irregularities of increased area and therefore an increase in total surface area of a treated surface to in turn increase permeation of the gas. Preferably, both surfaces of the membrane are treated by chemical etching techniques, although sand blasting and ion etching are other possible surface treatments in accordance with the present invention.
Patent CA-2406110-A1 (CA)
Title: Water spray web cooling apparatus for web dryer
Inventor: ZAGAR STEVEN J
IPC: F26B13/10
Filed: 2001-05-01
Abstract: Apparatus and a method for the evaporative cooling of a web (5) within a dryer in a compact manner. Excess fluid overspray is controlled, thereby avoiding problems with fluid depositing on internal surfaces of the dryer, which can cause mineral build-up and can result in web breaks or quality defects if fluid drips onto the web. More specifically, a water delivery system (15) is used which directs a water mist to the web by appropriate design and placement of the spray nozzles (18). The quantity of water delivered to the web is regulated, and is preferably based upon web temperature. Excess mist is controlled by directing hot air to effectively vaporize the excess mist before it is able to contact the internal surfaces of the dryer enclosure (10) and its internal components.